Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about SYNAPTIC PRUNING: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
SYNAPTIC PRUNING is a concept in neurodegeneration research. Key relationships include: activates, regulates, implicated in. Associated with ALS, Aging, Als. Connected to 140 entities in the SciDEX knowledge graph.
No AI portrait yet
| Name | SYNAPTIC PRUNING |
| Key Genes/Proteins | AGING, ALZHEIMER, ALZHEIMER'S DISEASE, AMYLOID, AMYOTROPHIC LATERAL SCLEROSIS, AND |
| Related Diseases | aging, Aging, Als, ALS, Alzheimer |
| Related Pathways | Amyloid |
graph TD
SYNAPTIC_PRUNING["SYNAPTIC PRUNING"]
SYNAPTIC_PRUNING -->|"activates"| neurodegeneration["neurodegeneration"]
SYNAPTIC_PRUNING -->|"activates"| Alzheimer["Alzheimer"]
SYNAPTIC_PRUNING -->|"activates"| Neurodegeneration["Neurodegeneration"]
SYNAPTIC_PRUNING -->|"activates"| Als["Als"]
SYNAPTIC_PRUNING -->|"activates"| Amyotrophic_Lateral_Sclerosis["Amyotrophic Lateral Sclerosis"]
SYNAPTIC_PRUNING -->|"activates"| Ms["Ms"]
SYNAPTIC_PRUNING -->|"regulates"| Autism["Autism"]
SYNAPTIC_PRUNING -->|"regulates"| Neuroinflammation["Neuroinflammation"]
complement_activation["complement activation"] -->|"activates"| SYNAPTIC_PRUNING
microglia["microglia"] -->|"activates"| SYNAPTIC_PRUNING
PYROPTOSIS["PYROPTOSIS"] -->|"activates"| SYNAPTIC_PRUNING
MICROGLIA["MICROGLIA"] -->|"activates"| SYNAPTIC_PRUNING
NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"] -->|"activates"| SYNAPTIC_PRUNING
NEURODEGENERATION["NEURODEGENERATION"] -->|"activates"| SYNAPTIC_PRUNING
ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"] -->|"activates"| SYNAPTIC_PRUNING
P62["P62"] -->|"activates"| SYNAPTIC_PRUNING
COMPLEMENT["COMPLEMENT"] -->|"inhibits"| SYNAPTIC_PRUNING| Target | Relation | Type | Str |
|---|---|---|---|
| Learning And Memory | regulates | process | 0.90 |
| Weakened Synapses | targets | phenotype | 0.90 |
| Synaptic Plasticity | regulates | process | 0.90 |
| Dysfunctional Synapses | targets | phenotype | 0.90 |
| MICROGLIA | activates | gene | 0.90 |
| Neuronal Activity | regulates | process | 0.85 |
| Aged Brain | expressed_in | brain_region | 0.85 |
| Synapse Formation | associated_with | process | 0.85 |
| Cognitive Decline | correlates_with | phenotype | 0.80 |
| Memory Strength | modulates | phenotype | 0.80 |
| Als | associated_with | disease | 0.75 |
| Inflammation | regulates | disease | 0.75 |
| Neurodegeneration | activates | disease | 0.75 |
| neurodegeneration | activates | process | 0.75 |
| Regulated Cell Death | associated_with | process | 0.70 |
| NEURON | activates | gene | 0.70 |
| OVERVIEW | regulates | gene | 0.70 |
| NEURON | implicated_in | gene | 0.70 |
| NEURODEGENERATIVE DISEASES | implicated_in | gene | 0.70 |
| PHAGOCYTOSIS | activates | gene | 0.70 |
| Phagocytosis | activates | pathway | 0.70 |
| Complement | associated_with | pathway | 0.70 |
| MICROGLIA | regulates | gene | 0.70 |
| COMPLEMENT | implicated_in | gene | 0.70 |
| INFLAMMATION | regulates | gene | 0.70 |
| Aging | associated_with | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Stroke | activates | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | activates | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| Parkinson | regulates | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Neurodegeneration | regulates | disease | 0.65 |
| Infection | implicated_in | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| Neuroinflammation | therapeutic_target | disease | 0.65 |
| Neurodegeneration | therapeutic_target | disease | 0.65 |
| Ms | regulates | disease | 0.65 |
| Epilepsy | associated_with | disease | 0.65 |
| Inflammation | therapeutic_target | disease | 0.65 |
| ALS | regulates | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| Depression | regulates | disease | 0.65 |
| Alzheimer | regulates | disease | 0.65 |
| Neuroinflammation | regulates | disease | 0.65 |
| Aging | regulates | disease | 0.65 |
| Autism | regulates | disease | 0.65 |
| Traumatic Brain Injury | regulates | disease | 0.65 |
| Alzheimer | therapeutic_target | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Microglia | mediates | cell_type | 0.95 |
| Complement | mediates | pathway | 0.95 |
| MICROGLIA | mediates | cell_type | 0.95 |
| Autophagy | involved_in | process | 0.95 |
| MICROGLIA | associated_with | gene | 0.90 |
| Complement System | mediates | pathway | 0.90 |
| CR3 | mediates | receptor | 0.85 |
| C1Q | involved_in | protein | 0.85 |
| C3 | involved_in | protein | 0.85 |
| C1q-C3-CR3 Pathway | mediates | pathway | 0.85 |
| C1q | involved_in | protein | 0.85 |
| Complement Inhibition | inhibits | mechanism | 0.85 |
| C1Q | mediates | protein | 0.85 |
| CR3 | involved_in | receptor | 0.85 |
| C1q | mediates | protein | 0.80 |
| TREM2 | enhances | gene | 0.80 |
| C1Q | enhances | gene | 0.80 |
| microglia | activates | cell_type | 0.70 |
| NEURODEGENERATION | activates | gene | 0.70 |
| Osteopontin | regulates | protein | 0.70 |
| trained microglia | hyperactive | cell_type | 0.70 |
| C1QA | facilitates | protein | 0.70 |
| complement activation | activates | process | 0.70 |
| TREM2 | therapeutic_target | gene | 0.60 |
| INFLAMMATION | regulates | gene | 0.60 |
| ALZHEIMER'S DISEASE | regulates | gene | 0.60 |
| C1Q/C3 | regulates | gene | 0.60 |
| OVERVIEW | regulates | gene | 0.60 |
| AND | regulates | gene | 0.60 |
| PARKINSON | regulates | gene | 0.60 |
| AND | inhibits | gene | 0.60 |
| NEUROINFLAMMATION | regulates | gene | 0.60 |
| SYNAPSE | activates | gene | 0.60 |
| C1Q | activates | gene | 0.60 |
| CYTOKINES | regulates | gene | 0.60 |
| COMPLEMENT | regulates | gene | 0.60 |
| TREM2 | contributes_to | gene | 0.60 |
| AND | activates | gene | 0.60 |
| STROKE | activates | gene | 0.60 |
| SYNAPSE | regulates | gene | 0.60 |
| DEMENTIA | therapeutic_target | gene | 0.60 |
| ALZHEIMER | therapeutic_target | gene | 0.60 |
| NEURODEGENERATION | implicated_in | gene | 0.60 |
| NEURODEGENERATIVE DISORDERS | therapeutic_target | gene | 0.60 |
| AGING | regulates | gene | 0.60 |
| BRAIN INJURY | regulates | gene | 0.60 |
| CD47 | regulates | gene | 0.60 |
| LYSOSOME | activates | gene | 0.60 |
| SQSTM1 | activates | gene | 0.60 |
| NEUROINFLAMMATION | therapeutic_target | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| LPS-primed microglial trained immunity establishes persisten | 0.670 | neurodegeneration | Synaptic pruning by microglia in neurode |
| TNF-α/IL-1β-Cx43 Hemichannel Axis as Upstream Link Between S | 0.663 | cell biology | What is the relative contribution of con |
| Complement-Mediated Synaptic Pruning Dysregulation | 0.612 | neurodegeneration | Gene expression changes in aging mouse b |
| Synaptic Pruning Precision Therapy | 0.612 | Alzheimer's disease | Neuroinflammation and microglial priming |
| TREM2 Agonism to Redirect Microglia from Synaptic Pruning to | 0.521 | neurodegeneration | How do ALS-associated OPTN mutations mec |
| Microglial TREM2 Activation to Enhance Synaptic Pruning Regu | 0.510 | connectomics | Human connectome alterations in Alzheime |
Scientific analyses that reference this entity
molecular biology | 2026-04-21 | 1 hypotheses Top: 0.582
neurodegeneration | 2026-04-02 | 7 hypotheses Top: 0.720
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.703
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Network pharmacology analysis of QTJD active compounds and pathways | exploratory | Mycoplasma pneumoniae pneumoni | 0.900 | 0.00 | computational network analysis | proposed | N/A |
| C1q neutralization experiment | validation | perioperative neurocognitive d | 0.900 | 0.00 | rats | proposed | N/A |
| scRNA-seq analysis of human atherosclerotic plaques | exploratory | Atherosclerosis | 0.900 | 0.00 | human atherosclerotic plaque s | proposed | N/A |
| Sevoflurane-induced neurotoxicity (SIN) model in rats | validation | perioperative neurocognitive d | 0.900 | 0.00 | rats | proposed | N/A |
| Machine learning-based identification of C1Q hub genes | exploratory | Atherosclerosis | 0.900 | 0.00 | Human bulk RNA sequencing data | proposed | N/A |
| Transcriptomic profiling and differential expression analysis | exploratory | Alzheimer's disease | 0.900 | 0.00 | 1-month-old APP/PS1 mice cereb | proposed | N/A |
| Gene expression validation in apoE-/- mice | validation | Atherosclerosis | 0.850 | 0.00 | apoE-/- mice | proposed | N/A |
| ox-LDL treatment of RAW264.7 macrophages | exploratory | Atherosclerosis | 0.850 | 0.00 | RAW264.7 macrophages | proposed | N/A |
| bEV-mediated synaptic pruning via C1q-C3 pathway | exploratory | Alzheimer's disease | 0.850 | 0.00 | microglia and synapses (in viv | proposed | N/A |
| Validation of hub genes in ox-LDL treated RAW264.7 macrophages | exploratory | Atherosclerosis | 0.800 | 0.00 | RAW264.7 macrophages | proposed | N/A |
| Validation of hub genes in apoE-/- atherosclerotic mice | validation | Atherosclerosis | 0.800 | 0.00 | apoE-/- mice | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Prolonged anesthesia induces neuroinflammation and complement-mediated microglia [PMID:36600274] | Xu F, Han L, Wang Y, Deng D, Ding Y, Zha | BMC Med | 2023 | 2 |
| Perivascular cells induce microglial phagocytic states and synaptic engulfment v [PMID:36747024] | De Schepper S, Ge JZ, Sierksma A, Crowle | Nat Neurosci | 2023 | 2 |
| Young adult microglial deletion of C1q reduces engulfment of synapses and preven [PMID:41000995] | Petrisko TJ, Chu SH, Gomez-Arboledas A, | bioRxiv : the preprint server | 2025 | 1 |
| Gut-derived bacterial vesicles carrying lipopolysaccharide promote microglia-med [PMID:40731189] | Zhao X, Yu J, Xu B, Xu Z, Lei X, Han S, | Alzheimer's & dementia : the j | 2025 | 1 |
| Trigeminal neuralgia. [PMID:38816415] | Ashina S, Robertson CE, Srikiatkhachorn | Nature reviews. Disease primer | 2024 | 1 |
| Microglia regulation of synaptic plasticity and learning and memory. [PMID:34472455] | Cornell J, Salinas S, Huang HY, Zhou M | Neural Regen Res | 2022 | 1 |
| The Role of Complement in Synaptic Pruning and Neurodegeneration. [PMID:34595138] | Gomez-Arboledas A, Acharya MM, Tenner AJ | ImmunoTargets and therapy | 2021 | 1 |
| Early complement genes are associated with visual system degeneration in multipl [PMID:31289819] | Fitzgerald KC, Kim K, Smith MD, Aston SA | Brain | 2019 | 1 |
| Opioid Receptors. [PMID:26332001] | Stein C | Annual review of medicine | 2016 | 1 |
| Sustained inhibitory dysfunction in complement component C1qa-deficient mice und [PMID:41544964] | Righes Marafiga J, Vu T, Bowlus J, Barab | Progress in neurobiology | 2026 | 0 |
| Synaptic pruning genes networks in Alzheimer's disease: correlations with neurop [PMID:40515808] | Sanfilippo C, Castrogiovanni P, Imbesi R | Geroscience | 2026 | 0 |
| Synaptic pruning genes networks in Alzheimer's disease: correlations with neurop [PMID:40515808] | Sanfilippo C, Castrogiovanni P, Imbesi R | GeroScience | 2026 | 0 |
| Alzheimer's Disease as a Disorder of Neuroimmune Dysregulation. [PMID:41745721] | Aranda-Abreu GE, Rojas-Durán F, Hernánde | Neurology international | 2026 | 0 |
| Sex-Specific Molecular Architecture of Microglia-Mediated Neuronal Pruning Acros [PMID:41324815] | Sanfilippo C, Castrogiovanni P, Imbesi R | Molecular neurobiology | 2025 | 0 |
| Proteomic discoveries in hypermobile Ehlers-Danlos syndrome reveal insights into [PMID:40972649] | Griggs M, Daylor V, Petrucci T, Weintrau | ImmunoHorizons | 2025 | 0 |
| The dopamine analogue CA140 alleviates AD pathology, neuroinflammation, and resc [PMID:39129007] | Chae S, Lee HJ, Lee HE, Kim J, Jeong YJ, | Journal of neuroinflammation | 2024 | 0 |
| Single-cell RNA sequencing reveals distinct immunology profiles in human keloid. [PMID:35990663] | ["Feng C", "Shan M", "Xia Y", "Zheng Z", | Frontiers in immunology | 2022 | 0 |
| [WALANT - Wide Awake Local Anaesthesia No Tourniquet: Complications in elective [PMID:35168268] | Wieschollek S, Forster S, Megerle K | Handchirurgie, Mikrochirurgie, | 2022 | 0 |
| Adaptive learning algorithms to optimize mobile applications for behavioral heal [PMID:33657217] | Figueroa CA, Aguilera A, Chakraborty B, | Journal of the American Medica | 2021 | 0 |
| Engineering complex communities by directed evolution. [PMID:33986540] | Chang CY, Vila JCC, Bender M, Li R, Mank | Nature ecology & evolution | 2021 | 0 |
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.68 · 2026-04-22
closed · Rounds: 4 · Score: 0.50 · 2026-04-21
closed · Rounds: 4 · Score: 0.95 · 2026-04-06
Hypotheses and analyses mentioning SYNAPTIC PRUNING in their description or question text